Microstructural White Matter Alterations in Men With Alcohol Use Disorder and Rats With Excessive Alcohol Consumption During Early Abstinence.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
pubmed:
4
4
2019
medline:
17
6
2020
entrez:
4
4
2019
Statut:
ppublish
Résumé
Although the detrimental effects of alcohol on the brain are widely acknowledged, observed structural changes are highly heterogeneous, and diagnostic markers for characterizing alcohol-induced brain damage, especially in early abstinence, are lacking. This heterogeneity, likely contributed to by comorbidity factors in patients with alcohol use disorder (AUD), challenges a direct link of brain alterations to the pathophysiology of alcohol misuse. Translational studies in animal models may help bridge this causal gap. To compare microstructural properties extracted using advanced diffusion tensor imaging (DTI) in the brains of patients with AUD and a well-controlled rat model of excessive alcohol consumption and monitor the progression of these properties during early abstinence. This prospective observational study included 2 cohorts of hospitalized patients with AUD (n = 91) and Marchigian Sardinian alcohol-preferring (msP) rats (n = 27). In humans cross-sectional comparison were performed with control participants (healthy men [n = 36]) and longitudinal comparisons between different points after alcohol withdrawal. In rats, longitudinal comparisons were performed in alcohol-exposed (n = 27) and alcohol-naive msP rats (n = 9). Human data were collected from March 7, 2013, to August 3, 2016, and analyzed from June 14, 2017, to May 31, 2018; rat data were collected from January 15, 2017, to May 12, 2017, and analyzed from October 11, 2017, to May 28, 2018. Fractional anisotropy and other DTI measures of white matter properties after long-term alcohol exposure and during early abstinence in both species and clinical and demographic variables and time of abstinence after discharge from hospital in patients. The analysis included 91 men with AUD (mean [SD] age, 46.1 [9.6] years) and 27 male rats in the AUD groups and 36 male controls (mean [SD] age, 41.7 [9.3] years) and 9 male control rats. Comparable DTI alterations were found between alcohol and control groups in both species, with a preferential involvement of the corpus callosum (fractional anisotropy Cohen d = -0.84 [P < .01] corrected in humans and Cohen d = -1.17 [P < .001] corrected in rats) and the fornix/fimbria (fractional anisotropy Cohen d = -0.92 [P < .001] corrected in humans and d = -1.24 [P < .001] corrected in rats). Changes in DTI were associated with preadmission consumption patterns in patients and progress in humans and rats during 6 weeks of abstinence. Mathematical modeling shows this process to be compatible with a sustained demyelination and/or a glial reaction. Using a translational DTI approach, comparable white matter alterations were found in patients with AUD and rats with long-term alcohol consumption. In humans and rats, a progression of DTI alterations into early abstinence (2-6 weeks) suggests an underlying process that evolves soon after cessation of alcohol use.
Identifiants
pubmed: 30942831
pii: 2729425
doi: 10.1001/jamapsychiatry.2019.0318
pmc: PMC6583663
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
749-758Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA017447
Pays : United States
Organisme : NIAAA NIH HHS
ID : P60 AA006420
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA015566
Pays : United States
Références
J Neurosci. 2010 Jun 16;30(24):8285-95
pubmed: 20554880
Alcohol Clin Exp Res. 2018 May;42(5):889-896
pubmed: 29543332
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
J Magn Reson B. 1994 Mar;103(3):247-54
pubmed: 8019776
Br Med J. 1964 Jul 18;2(5402):177
pubmed: 14150898
Alcohol Clin Exp Res. 2012 Nov;36(11):1922-31
pubmed: 22551067
AJNR Am J Neuroradiol. 2012 May;33(5):928-34
pubmed: 22241391
Neuroimage. 2008 Apr 1;40(2):570-582
pubmed: 18255316
Alcohol Clin Exp Res. 1996 Jun;20(4):752-7
pubmed: 8800395
J Neurosci. 2014 Nov 12;34(46):15425-36
pubmed: 25392509
Neuropsychol Rev. 2007 Sep;17(3):239-57
pubmed: 17874302
Alcohol Clin Exp Res. 2000 Aug;24(8):1214-21
pubmed: 10968660
Neuropsychopharmacology. 2005 Feb;30(2):423-32
pubmed: 15562292
Drug Alcohol Depend. 2017 Jun 1;175:42-50
pubmed: 28384535
Neuroimage. 2002 Mar;15(3):708-18
pubmed: 11848714
Hum Brain Mapp. 2012 Oct;33(10):2390-406
pubmed: 21823209
Neuroimage. 2009 Apr 1;45(2):386-92
pubmed: 19150655
Addict Biol. 2020 Jan;25(1):e12717
pubmed: 30748046
BMJ. 2017 Jun 6;357:j2353
pubmed: 28588063
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Psychophysiology. 2011 Dec;48(12):1711-25
pubmed: 21895683
Addict Biol. 2017 Sep;22(5):1459-1472
pubmed: 27273582
Alcohol Alcohol. 2017 Mar 9;52(2):145-150
pubmed: 28182205
J Neurol Sci. 1989 Aug;92(1):81-9
pubmed: 2769304
Psychiatry Res. 2009 Jul 15;173(1):22-30
pubmed: 19442492
PLoS One. 2015 Apr 20;10(4):e0124885
pubmed: 25894968
Neuroimage. 2009 Jul 1;46(3):786-802
pubmed: 19195496
Neurology. 2001 Jun 26;56(12):1727-32
pubmed: 11425941
Addict Biol. 2006 Sep;11(3-4):339-55
pubmed: 16961763
J Neurol Neurosurg Psychiatry. 1988 Jul;51(7):909-13
pubmed: 3204399
Addict Biol. 2010 Apr;15(2):169-84
pubmed: 20148778
Biol Psychiatry. 2009 Apr 15;65(8):680-90
pubmed: 19103436
Magn Reson Med. 2009 May;61(5):1255-60
pubmed: 19253405
Neuroimage. 2014 Apr 1;89:35-44
pubmed: 24342225